Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. - Wikidata - awgldk - TriplyDB

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

http://www.wikidata.org/entity/Q37423412

about

Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3 Pharmacological inhibition of feline immunodeficiency virus (FIV)Progression of temporal processing deficits in the HIV-1 transgenic rat Strain-specific viral distribution and neuropathology of feline immunodeficiency virus Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Replication properties of clade A/C chimeric feline immunodeficiency viruses and evaluation of infection kinetics in the domestic cat Selection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitors Feline models of viral pathogenesis: opportunity knocks.Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

P2860

Q24801797-E224AF72-F243-4641-838E-31532557078B Q26995310-962457F3-F8F3-40C1-B3DE-453D484F9B76 Q30374656-9670695C-DFA5-49B3-8D86-20C64A7D325B Q30462523-FA47D253-8966-44E9-9F9F-F3ECD91CA345 Q33990752-7DDE32F4-7BEE-4D20-884C-2DD0C133E244 Q36845611-E04F1CF2-8EDC-46D0-8BB3-FD1C776DC1EB Q37036823-403E6C53-ADB6-4BEC-8790-C8B139B792DB Q41700124-A431BA30-07EF-4AD5-9DF9-5871E8371207 Q44742776-079D0D20-C168-41A1-A954-2EE960946355 Q46238563-8D75B1F4-455C-43C1-9607-BC7F1CB5FD56

P2860

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

http://www.wikidata.org/entity/Q37423412

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@en

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@nl

type

label

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@en

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@nl

prefLabel

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@en

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@nl

P1433

Q37423412-927D20E9-9106-419E-AB91-E36A1E5E1501

P1476

Q37423412-80E20646-9C66-4BC5-AEDE-1784A40FAFCC

P2093

Q37423412-02ADAE1A-8F47-48BE-BB03-0345EF911573

Q37423412-1C6A263E-6F7C-4B92-8F94-B2C0A3000E6D

Q37423412-25D51925-43EB-4E7F-89A0-653B8D3B1E9C

Q37423412-3AFE7B9A-4FED-43DE-AFF2-F892D1181C39

Q37423412-5D34504A-9DD5-45CE-82EC-4E5F73D1437B

Q37423412-92B6859D-33D1-4629-95F8-B7B6F291242C

Q37423412-BB75FF38-4A2A-47A6-B9F3-44349A1D66AE

Q37423412-CBF0E063-1A76-46B2-B10C-47E9966C3819

Q37423412-CE64EC3F-0A23-4E62-8618-AE141324D203

Q37423412-EF886922-A808-4F5A-9945-420005AD6C35

P2860

Q37423412-02D3720F-E492-4D3D-AA66-48C930973156

Q37423412-16B2A95B-43A3-4DED-9078-BEDF770C869A

Q37423412-2781326C-9A1F-4568-A00B-2B25ED955312

Q37423412-315BCB64-24E6-43E4-8660-587ACE85A5A3

Q37423412-315DA8BD-727D-4417-96CE-9B296289B3B2

Q37423412-3737EF4A-091C-4196-84D5-C307812BE987

Q37423412-4255EF47-9FCE-4DD1-B422-D6B7B1026ACB

Q37423412-44A11C44-F29C-43A7-BAF0-10A98F413C2B

Q37423412-474472FF-D72D-4B1F-A74A-015FF8FDDBE9

Q37423412-57CA7B63-197A-4022-A49A-911F0458265A

P304

Q37423412-62AAB90D-46C1-4A81-9DDC-4C655DC1A8B2

P31

Q37423412-C2F335EC-C638-4460-80C2-477F52005827

P356

Q37423412-013E1CA2-5316-41E9-90C9-708AD6D2F4B0

P407

Q37423412-94A6FEE6-3367-444D-A6F9-F63E98BAB844

P433

Q37423412-24A919F1-B556-43DD-8876-D5D75BAAB6F7

P478

Q37423412-2C1A3DD6-25E0-4D56-8B79-9494A3833258

P50

Q37423412-36C2C046-A487-4D18-B13A-DFDD85648F1E

Q37423412-AAA125F1-FFEE-4558-9F33-98F1D56585D7

P577

Q37423412-BB649B3A-E6DA-47F6-B9F9-3B34F82FFCB3

P5875

Q37423412-FBE0AC10-7A88-4C9A-88E9-859C2B34C866

P698

Q37423412-3A3E6606-FDE0-4578-87F7-BA1110917B88

P932

Q37423412-835142E2-0B1F-4687-AD82-C8F873F489A4

P356

JVI.78.9.4525-4532.2004

P1433

Journal of Virology

P1476

Resolution and prevention of f ...... h the protease inhibitor TL-3.

@en

P2093

Bernd Bühler

http://www.w3.org/2001/XMLSchema#string

Bruce E Torbett

http://www.w3.org/2001/XMLSchema#string

Danica L Lerner

http://www.w3.org/2001/XMLSchema#string

John H Elder

http://www.w3.org/2001/XMLSchema#string

Mboya Burudi

http://www.w3.org/2001/XMLSchema#string

Nicholas W Henriksen

http://www.w3.org/2001/XMLSchema#string

Salvador Huitron-Resendiz

http://www.w3.org/2001/XMLSchema#string

Sohela De Rozières

http://www.w3.org/2001/XMLSchema#string

Steven Henriksen

http://www.w3.org/2001/XMLSchema#string

Ying-Chuan Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease

Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.

Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

Sleep patterns are disturbed in cats infected with feline immunodeficiency virus

Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.

Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus.

P304

4525-4532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.78.9.4525-4532.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Sanchez-Alavez

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8623898

http://www.w3.org/2001/XMLSchema#string

P698

15078933

http://www.w3.org/2001/XMLSchema#string

P932

387718

http://www.w3.org/2001/XMLSchema#string